Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Finasteride affects brain stress and enzyme activity differently in various regions, possibly helping with liver-related brain issues.

FGF-5 promotes Cashmere goat hair growth by increasing keratin genes and reducing certain LncRNA and target genes.

MK-386 reduces sebum DHT levels.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Plant extracts may help treat hormone-related hair loss.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

The method accurately and quickly measures silodosin and dutasteride in mixtures.

Low PON1 levels may indicate and predict the severity of hair loss.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

The transporter protein SH1446 in Staphylococcus hominis is key to underarm odor production.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

AC5 improves hair loss and hair quality with high satisfaction rates.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

A new method accurately measures amino acids in treated hair, showing bleaching reduces amino acids while protein treatments increase them.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The process effectively regenerates the Pd/C catalyst for finasteride synthesis.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

We need better ways to test and understand SARMs to make safer and more effective treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Atg5 can promote tumors when autophagy is deficient but suppresses them under normal conditions.